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ADEQUATE DISTRIBUTION 
OF WARM CARDIOPLEGIC 
SOLUTION 
Seventy-five patients undergoing coronary artery bypass grafting were ran- 
domized to receive warm antegrade (N = 25), warm retrograde (N = 25), or a 
combination of warm antegrade and retrograde (N = 25) delivery of blood 
cardioplegic solution. Myocardial oxygen utilization, lactate and acid metab- 
olism, and adenine nucleotides and their degradation products were measured 
during the operation and cardiac function was assessed postoperatively. Warm 
retrograde delivery of cardioplegic solution increased lactate and acid release 
during cardioplegia and reperfusion, decreased left ventricular adenosine 
triphosphate concentrations, and reduced the washout of adenine nucleotide 
degradation products from both left and right ventricles. Warm antegrade 
delivery of cardioplegic solution resulted in less lactate and acid release during 
cardioplegia but more lactate accumulated in the territory of the ler anterior 
descending artery during the crossclamp period. Intermittent antegrade 
delivery of the cardioplegic solution during combination cardioplegia washed 
out lactate and acid, which suggested inhomogeneous delivery of the cardiople. 
gic solution during continuous retrograde cardioplegia. Combination cardio- 
plegia best preserved adenosine triphosphate in the lefl ventricle and resulted 
in the best postoperative l ft and right ventricular function. A combination of 
intermittent antegrade and continuous retrograde delivery of cardioplegic 
solution provided better myocardial protection than either antegrade or 
retrograde delivery of cardioplegic solution alone. (J THORAC CARDIOVASC 
SURG 1995;110:800-12) 
Nobuhiko Hayashida, MD, John S. Ikonomidis, MD,* 
Richard D. Weisel, MD,** Toshizumi Shirai, MD Joan Ivanov, RN, 
Susan Carson, AHT, Molly K. Mohabeer, BSc, Laura C. Tumiati, BSc, and 
Donald A. G. Mickle, MD, Toronto, Ontario, Canada 
N ormothermic blood cardioplegia offers the 
promise to resuscitate the ischemic myocardium 
and reduce the morbidity and mortality for patients 
From the Division f Cardiovascular Surgery, Department of 
Clinical Biochemistry, and the Center for Cardiovascular 
Research, The Toronto Hospital and the University of To- 
ronto, Toronto, Ontario, Canada. 
Presented at the Sixty-sixth Scientific Sessions of the American 
Heart Association, Atlanta, Ga., Nov. 9, 1993. 
Supported by the Medical Research Council of Canada (grant 
MT9829) and the Heart and Stroke Foundation of Ontario 
(grant B2267). 
Received for publication May 17, 1994. 
Accepted for publication Dec. 20, 1994. 
Address for reprints: Richard D. Weisel, MD, The Toronto 
Hospital, 200 Elizabeth St., EN 14-215, Toronto, Ontario 
M56 2C4, Canada. 
*Fellow of the Medical Research Council of Canada. 
**Career Investigator of the Heart and Stroke Foundation of 
Ontario. 
Copyright © 1995 by Mosby-Year Book, Inc. 
0022-5223/95 $ .00 + 0 12/1/63011 
800 
with high-risk disease. Warm antegrade delivery of 
cardioplegic solution maintains myocardial oxygen 
consumption and reduces anaerobic lactate produc- 
tion, provided the flow rate is greater than 80 
ml/min and the hemoglobin level is greater than 80 
gm/LJ However, coronary occlusions, particularly 
of the left anterior descending artery, limit perfusion 
of cardioplegic solution when an arterial conduit is 
used to bypass this artery. 2Retrograde cardioplegia 
permits delivery of cardioplegic solution to the 
region of the left anterior descending artery despite 
a coronary occlusion, 2 but may provide limited 
perfusion to the posterior septum and right ventri- 
cle. 3 Therefore a combination of antegrade and 
retrograde delivery of cardioplegic solution may be 
required to provide adequate myocardial perfusion 
during warm blood cardioplegia. 
This prospective randomized clinical trial was 
performed in patients at low risk for adverse clinical 
outcomes to document differences of myocardial 
metabolism and ventricular function. We previously 
demonstrated that patients undergoing elective op- 
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Table I. Clinical data 
Antegrade Combination Retrograde p Value 
No. of pat ients 25 25 25 
Age (yr) 58 _+ 2 58 -+ 2 58 _+ 2 0.99 
Gender (M/F) 24/1 24/1 23/2 0.77 
NYHA class (II/III/IV) 3/13/9 0/14/11 1/13/11 0.44 
Left maftn disease (Y/N) 2/23 4/21 4/21 0.93 
LVEF (>0.6/0.4-0.6/<0.4) 12/10/3 9/11/5 11/13/1 0.48 
Urgent operation 4 8 4 0.29 
Grafts (2/3/4/5) 3/5/12/5 0/4/18/3 2/8/13/2 0.31 
XCL time (min) 65 _+ 3 69 _+ 3 59 -+ 3 0.06 
CPB time (min) 98 _+ 3 97 _+ 3 87 +_ 4 0.07 
Ages and times are given as the mean value plus or minus the standard error of the mean. The p values refer to the results of analysis of variance for 
continuous variables and I, 2 or Fisher's exact est for categoric variables. M,, Male; F, female; NYHA, New York Heart Association; Y, yes; N, no; LVEF, left 
ventricular ejection fraction; XCL, crossclamp. 
erations who received blood rather than crystalloid 
cardioplegia had improved metabolic recovery and 
better postoperative ventricular function. 4We were 
then able to demonstrate that blood cardioplegia 
reduced the risks of urgent operations for unstable 
angina by reducing perioperative morbidity and 
mortality. 5 Therefore in this prospective, clinical 
trial we evaluated myocardial metabolism and ven- 
tricular function to determine whether subtle differ- 
ences could be found. The finding of a significant 
benefit with combination cardioplegia would allow 
us to anticipate performance of a large randomized, 
clinical trial in patients with high-risk conditions to 
determine whether this cardioplegic technique will 
reduce morbidity and mortality. 
Methods 
Patient population. Seventy-five patients cheduled for 
isolated coronary artery bypass graffing by one surgeon 
agreed to participate in this study of alternative cardiople- 
gic techniques. All patients signed a consent form ap- 
proved by the human experimentation committee. Pa- 
tients admitted to the study were 36 to 77 years old, had 
double- or triple-vessel coronary artery disease, and had 
adequate preoperative ventricular function (left ventricu- 
lar ejection fraction greater than 30% by preoperative 
single-plane contrast ventriculography). Table I describes 
the clinical data of patients in this study. 
Operative technique. Cardiopulmonary bypass (CPB) 
was established with a single two-stage right atrial can- 
nula. During bypass, the hematocrit value was maintained 
between 20% and 25%, pump flows between 2.0 and 2.5 
L/min per square meter, and mean arterial pressure 
between 50 and 60 mm Hg, with administration of sodium 
nitroprusside or phenylephrine hydroehloride as required. 
Patients were not actively cooled but their systemic tem- 
peratures were allowed to drift to 33 ° _+ 1 ° C. Rewarming 
was begun during construction of the last three anasto- 
moses. A left internal mammary artery was anastomosed 
to the left anterior descending coronary artery as the last 
graft in aH patients. 
Cardioplegia groups. Patients were randomly assigned, 
by means of computer-generated randomization table, to 
one of three cardioplegic strategies (Table I and Fig. 1). 
Blood cardioplegic solution was prepared by mixing 
four parts of oxygenated blood to each part of crystalloid 
solution 1and was delivered by the Buckberg-Shiley Plus 
system (Shiley Inc., Irvine, Calif.). In all patients, cardiac 
arrest was achieved with an antegrade infusion of 500 ml 
high-potassium cardioplegic solution (containing 27 
mEq/L of potassium) delivered into the aortic root at 
37 ° C and at a pressure of 70 mm Hg measured through a
separate port of the solution cannula (for antegrade 
delivery of cardioplegic solution, DLP Inc., Grand Rapids, 
Mich.; for antegrade/retrograde delivery of cardioplegic 
solution, Research Medical Inc., Midvale, Utah). 
Antegrade delivery of cardioplegic solution (antegrade 
cardioplegia; N = 25). After cardiac arrest, low-potas- 
sium cardioplegic solution (containing 13 mEq/L potas- 
sium) at 37 ° C was delivered into the aortic root at a flow 
rate of 200 ml/min. Flow of the cardioplegic solution was 
interrupted, and the aortic root vented, whenever neces- 
sary to permit adequate visualization during the critical 
portion of distal anastomosis construction. After the 
completion of each distal anastomosis, the vein grafts 
were attached to a manifold system to allow delivery of 
cardioplegic solution into the aortic root and all com- 
pleted vein grafts. During subsequent distal anastomoses 
cardioplegic solution was delivered into vein grafts with 
the aortic root vented. A "catch-up" retrograde infusion 
was given after each interruption in a volume that was 
calculated by the perfusionist to precisely compensate for 
the period of cessation of flow and to maintain the 
average cardioplegic solution flow rate near 150 tal/min. 
Retrograde delivery of blood cardioplegic solution (retro- 
grade cardioplegia; N = 25). After cardiac arrest was 
achieved with the initial antegrade infusion, the aortic 
root was vented and retrograde delivery of cardioplegic 
solution was begun via the coronary sinus cannula (Re- 
search Medical Inc.) at a flow rate of 200 tal/min. Coro- 
nary sinus pressure was monitored continuously by the 
separate pressure monitoring line and maintained at less 
than 40 mm Hg throughout the procedure. Distal and 
proximal anastomoses were constructed in an alternating 
manner. As in the antegrade group, flow of the cardio- 
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Fig. 1. Cardioplegic techniques are depicted. In the combination and retrograde groups, proximal 
anastomoses were constructed after each distal anastomosis during retrograde infusions of cardioplegic 
solution. LIMA, Anastomoses of left internal mammary artery; SVG, anastomoses of saphenous vein grafts; 
PROX, proximal anastomoses of saphenous vein grafts; XCL, aortic crossclamp. 
plegic solution was interrupted whenever necessary to 
achieve adequate visualization during construction of 
distal anastomoses. A "catch-up" infusion was given to 
maintain the average flow rate near 200 ml/min. 6
Combination of antegrade and retrograde delivery of 
cardioplegic solution (combination cardioplegia; N = 25). 
Cardioplegic solution was given in a manner identical to 
that of warm retrograde cardioplegia. A "catch-up" ret- 
rograde infusion was given after each interruption for the 
construction of a distal anastomosis. In addition, ante- 
grade intermittent infusions of cardioplegic solution (250 
ml) were given through the aortic root at a flow rate 
sufficient o maintain aortie root pressure at 50 mm Hg 
after completion of each proximal anastomosis. Infusion 
of the cardioplegic solution was never done simulta- 
neously in an antegrade and retrograde manner. 
The three cardioplegic techniques are illustrated in Fig. 1. 
Oxygen, lactate, and pH assays. Arterial and coronary 
sinus blood samples were obtained simultaneously during 
bypass before application of the crossclamp, immediately 
after crossclamp release, 10 minutes after crossclamp 
removal, and 10 minutes after CPB was discontinued. To 
uncover any latent anaerobic metabolism, arterial and 
coronary sinus samples were also taken after 5 minutes of 
atrial pacing at a rate of 110 beats/min during bypass 10 
minutes after crossclamp release and 10 minutes after 
discontinuation of CPB. 
During crossclamping, cardioplegic solution and coro- 
nary venous blood samples were obtained every 10 min- 
utes in the antegrade group and immediately before the 
completion of proximal anastomoses during retrograde 
delivery of cardioplegic solution in both the retrograde 
group and the combination group. Additional blood sam- 
ples were taken 30 seconds after the initiation of inter- 
mittent antegrade delivery of cardioplegic solution in the 
combination group. Coronary venous amples were taken 
from the coronary sinus during antegrade cardioplegic 
solution delivery and from the aortic root during retro- 
grade cardioplegic solution delivery. 
Blood samples were assayed for the partial pressure of 
oxygen (Po2) and carbon dioxide, pH (Acid-Base Labo- 
ratory, Radiometer, Copenhagen, Denmark), and oxygen 
saturation (Co-Oximeter, Instrumentation Laboratory 
Inc., Lexington, Mass.). Oxygen content (O2Con) was 
calculated from the formula 
O2Con = 1.39Hgb × S + 0.0031Po2 
where Hgb is the hemoglobin concentration and S is the 
oxygen saturation. Myocardial oxygen extraction was cal- 
culated as the arterial or cardioplegic solution oxygen 
content minus the coronary venous oxygen content. Mea- 
surements were made at 37°C and corrected to the 
myocardial temperature at the time of sampling, which 
was measured in the region of the left anterior descending 
artery with a temperature probe. 1' 6.7 
Blood samples for lactate concentration were mixed 
with a measured volume of 6% perchloric acid. Lactate 
concentration was measured in the protein-free superna- 
tant by an enzymatic method (Rapid Lactate Stat Pack kit; 
Calbiochem-Behring, La Jolla, Calif.). Myocardial lactate 
extraction was calculated in the same manner as oxygen 
extraction. Negative lactate extraction was expressed as 
lactate production. 
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The concentration of hydrogen ion ([H÷]) in each 
blood sample was determined by converting the measured 
pH value to [H +] by the formula [H +] = antilog ( -pH).  
Measurements were made at 37 ° C and corrected to the 
myocardial temperature atthe time of sampling. Myocar- 
dial acid production was calculated as the coronary venous 
etttuent [H ÷] minus the arteriat or cardioplegic solution 
[H+]. 
During cardioplegic arrest myocardial consumption of 
oxygen, laetate release, and acid release were calculated as 
cardioplegic solution flow multiplied by the difference 
between the arterial and coronary sinus content. 1'7 
Myocardial adenine nucleotides, degradation produets, 
and lactate concentration. Transmural left and right ven- 
trieular biopsy specimens were obtained with a Tru-Cut 
biopsy needle (Travenol Labs, Deerfield, Ill.) from the 
territory of the left anterior deseending coronary artery 
and right ventrieular free wall to determine myocardial 
eoncentration of adenosine triphosphate (ATP), adeno- 
sine diphosphate (ADP), adenosine monophosphate 
(AMP), and total adenine nucleotide degradation prod- 
ucts (TDP = adenosine + inosine + hypoxanthine +
xanthine) in 36 patients (12 patients in eaeh eardioplegia 
group). Myocardial lactate concentrations were measured 
in 39 patients (13 patients in eaeh eardioplegia group). 
The computer-generated randomization table allocated 
patients to have biopsy studies allocated to adenine 
nucleotides or lactate on a random basis. The specimens 
were flash-frozen i  liquid nitrogen and then freeze dried. 
Myocardial adenine nucleotides and degradation products 
were measured by high-performance liquid chromatogra- 
phy, with a modification of the step gradient echnique 
described by Hull-Ryde and associates, s Myocardial lac- 
tate concentrations were measured by spectrophotometric 
techniques (Greiner Selective Analyzer II, Greiner Elec- 
tronics, Langenthal, Switzerland; Perkin-Elmer 650-150 
fluorescence spectrometer, Perkin-Elmer Corp., Norwalk, 
Conn.). 9 Biopsy samples were taken at 37 ° C during CPB 
before crossclamp application, immediately after release 
of the crossclamp, and again after 10 minutes of reperfu- 
sion. 
tlemodynamie measurements. Heart rate (HR), mean 
arterial blood pressure (MAP), mean pulmonary artery 
pressure (MPA), mean right atrial pressure (RAP), and 
pulmonary capillary wedge pressure (PCWP) were mea- 
sured. Cardiac output (CO) was measured with the ther- 
modilution technique. Derived hemodynamic indices 
were calculated as follows: cardiac index (CI) = CO/body 
surface area (liters per minute per square meter); stroke 
index (SI) = CI/HR (milliliters per minute per square 
meter); left ventricular stroke work index = SI x (MAP - 
PCWP) × 0.0136 (grams. meter per square meter); right 
ventricular stroke work index = SI × (MPA - RAP) × 
0.0136 (grams. meter per square meter). These hemody- 
namic variables were measured before initiation of CPB 
and at 10 minutes, 1 hour, 4 hours, 12 hours, and 24 hours 
after cessation of CPB. The relationships between left 
and right ventricular stroke work indices and the corre- 
sponding atrial pressures were evaluated by an analysis 
of covariance. Postoperative votume repletion followed 
a standard protocol and was done by persons who 
Table II. Clinical outcomes 
Antegrade Combination Retrograde p Value 
No. of patients 25 25 25 
Deaths 0 1 2 0.36 
MI 0 3 1 0.16 
LOS 1 3 2 0°59 
IABP 1 1 2 0~77 
Stroke 1 0 0 037 
The p values refer to the results of analysis of variance for continuous 
variables and X 2 or Fisher's exact est for categoric variables. M/, Myocar- 
dial infarction; LOS, low output syndrome; IABP, intraaortic balloon pump 
assistance. 
were unaware of the intraoperative cardioplegic tech- 
nique used. 
Creatine kinase. An antibody inhibition technique 
was used to measure the MB isozyme of creatine kinase 
(CK-MB). The sequential CK-MB measurements were 
done 2, 4, 8, 16, 24, and 48 hours after crossclamp release. 
Integration of the area under the concentration-time 
curve for CK-MB allowed calculation of the total CK-MB 
release, expressed as units times hours per liter)' 6, 7 
Statistical analysis. Statistical analysis was done with 
the SAS program (SAS Institute, Cary, N.C.). Analysis of 
variance was used to test the effect of cardioplegic strat- 
egies on myocardial oxygen utilization, lactate and acid 
metabolism, concentration of adenine nucleotides, degra- 
dation products and myocardial lactate, hemodynamic 
variables, and postoperative CK-MB release. When anal- 
ysis of variance indicated a significant effect of cardiople- 
gic group or time (p < 0.05), the differences were specified 
with Duncan's multiple range test. Continuous variables 
are listed as the mean and standard error of the mean. 
Categoric data are displayed as the absolute and percent 
frequency, and were analyzed by X a or Fisher's exact ests 
where appropriate. Statistical significance was assumed at 
a probability level of less than 0.05. 
For the hemodynamic data an analysis of covariance 
was needed to compare the three cardioplegic groups for 
the relation between left or right ventricular stroke work 
index or cardiac index and pulmonary capillary wedge 
pressure. 
Results 
Operative variables. Table I indicates that the 
number of bypass grafts was not different among 
cardioplegic groups (p = 0.31). However, the retro- 
grade groups tended to have fewer bypasses and 
shorter crossclamp (p = 0.06) and bypass (p = 0.07) 
times. When these times were corrected by the 
number of grafts, the crossclamp time per graft (p = 
0.47) and the CPB time per graft (p = 0.20) were not 
different among groups. 
Ciinical outcomes. The clinical outcomes are 
shown in Table II. Two of the patients in the 
retrograde cardioplegia group and one of the pa- 
tients in the eombination cardioplegia group died in 
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this series of 75 patients (4%). Two patients with 
diffuse triple-vessel disease who received retrograde 
cardioplegia died of heart failure despite balloon 
pump and inotropic support. One patient who re- 
ceived combination cardioplegia required an exten- 
sive bowel resection because of an ischemic bowel 
syndrome 11 days after bypass operation and died of 
renal failure 83 days after operation. Four patients 
had a perioperative myocardial infarction (defined 
as either new Q waves or ischemic ST segment 
changes with a concomitant rise in CK-MB levels). 
Six patients had low output syndrome (defined as 
the requirement for an intraaortic balloon pump or 
inotropic support for more than 30 minutes despite 
optimization of preload and afterload). Intraaortic 
balloon pump support was required postoperatively 
in four patients. The prevalence of these events was 
not statistically different between groups. 
Six patients required inotropic medication and 
four of these six patients required intraaortic bal- 
loon pumping after operation because of transient 
ventricular dysfunction in the operating room. In 
the intensive care unit only one of the six patients 
had a low left ventricular stroke work index 
(9 gin. m/m 2) at an elevated pulmonary artery 
wedge pressure (19 mm Hg). The remaining five 
patients had normal hemodynamics but they were 
receiving mechanical or inotropic assistance, or 
both. The hemodynamics in these six patients were 
first included in our analysis to provide an intention- 
to-treat evaluation. Then the results from these six 
patients were excluded to provide an efficacy analy- 
sis. Four patients had a perioperative myocardial 
infarction. In two of these four patients the highest 
CK-MB levels were less than 50 U/L and the CK-MB 
percent was less than 7% of the total CK level. The 
other two patients had higher levels of CK-MB. 
First, our evaluation of postoperative CK-MB level 
included all patients with an intention-to-treat anal- 
ysis. Our second evaluation excluded those patients 
who had a myocardial infarction for an evaluation of« 
efficacy. 
Cardioplegic solution flow rates and eontinuity. 
The initial antegrade cardioplegic solution infusion 
had similar flow rates among groups (antegrade 
cardioplegia, 310 -+ 18 tal/min; retrograde cardio- 
plegia, 325 _+ 22 tal/min; eombination cardioplegia, 
331 +_ 23 ml/min). The mean cardioplegic solution 
flow rate during continuous cardioplegia (excluding 
intermittent antegrade delivery of cardioplegic solu- 
tion in the combination group) during aortic cross- 
clamping was similar among groups (antegrade car- 
dioplegia, 144 _ 11 ml/min; retrograde cardioplegia, 
163 +_ 13 ml/min; combination cardioplegia, 147 ___ 
10 ml/min). Antegrade and retrograde infusions 
were intended to be provided at rates of 200 ml/min 
and "catch-up" infusions were intended to restore 
the 200 ml/min value. However, a careful stopwatch 
recording of the cardioplegic solution flow rates 
divided by the crossclamp time indicated that the 
actual infusions were less than 200 ml/min. There 
were no significant differences among groups in the 
actual infusion rates as recorded by our observers. 
In the combination group, the infusion of 250 ml 
intermittent antegrade cardioplegic solution was 
given 2.6 + 0.2 times per case at a flow rate of 302 _+ 
16 ml/min. Cardioplegia was interrupted for a 
greater (p < 0.05) percentage of the crossclamp 
period during antegrade cardioplegia (antegrade 
cardioplegia, 36% __ 4%; combination cardioplegia, 
17% + 3%; retrograde cardioplegia, 28% + 4%). 
The combination cardioplegia group received more 
cardioplegic solution (antegrade, 4.6 _+ 0.2 L; com- 
bination, 6.3 -+ 0.4 L; retrograde, 4.8 _+ 0.3 L; p = 
0.001). 
Myocardial metabolism during cardioplegia. 
Myocardial oxygen consumption, lactate release, 
and acid release at 30 minutes and 50 minutes of 
crossclamping are shown in Fig. 2. Myocardial oxy- 
gen consumption was significantly (p = 0.0001 by 
two-way analysis of variance) greater with antegrade 
cardioplegia nd intermittent antegrade delivery of 
cardioplegic solution in combination cardioplegia 
than with retrograde cardioplegia or retrograde 
delivery of cardioplegic solution in combination 
cardioplegia, probably because coronary venous 
blood from the aortic root was contaminated with 
bronchial arterial blood. 6 At 50 minutes of cross- 
clamping, myocardial oxygen consumption was 
greatest with intermittent antegrade delivery of car- 
dioplegic solution in the combination group than 
with either antegrade or retrograde cardioplegia, 
perhaps repaying an oxygen debt accumulated dur- 
ing continuous retrograde cardioplegia. 
Myocardial lactate release increased with time 
during retrograde but not antegrade or combination 
cardioplegia nd the interaction between cardiople- 
gic group and time was significant (p = 0.01 by 
two-way analysis of variance). Lactate release in- 
creased (p < 0.05) during retrograde but not during 
antegrade or combination cardioplegia by Duncan's 
test. Intermittent antegrade delivery of cardioplegic 
solution during combination cardioplegia resulted in 
greater (p < 0.05) lactate release at 30 minutes and 
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50 minutes of crossclamping than antegrade or 
retrograde cardioplegia, which suggests the washout 
of lactate accumulated uring continuous retro- 
grade cardioplegia. 
Myocardial acid release increased with time in the 
retrograde but not the antegrade cardioplegia group 
and the interaction between cardioplegic group and 
time was significant (p = 0.02 by two-way analysis of 
variance). Acid release increased (p < 0.05) during 
retrograde cardioplegia by Duncan's test. Intermit- 
tent antegrade delivery of cardioplegic solution in 
combination cardioplegia had the greatest (p < 
0.05) acid release at 30 minutes and 50 minutes of 
crossclamping. Retrograde cardioplegia had greater 
(p < 0.05) acid release than antegrade cardioplegia 
at 50 minutes of crossclamping. 
Myocardial metabolism during reperfusion. Myo- 
cardial oxygen extraction, laetate production, and 
acid production before crossclamping and during 
reperfusion are shown in Fig. 3. Myocardial oxygen 
extraction was greater after retrograde cardioplegia 
at the time of crossclamp removal and 10 minutes 
after discontinuation of CPB. Laetate production 
was found in all three groups immediately after 
crossclamp release and tended to be less after 
combination cardioplegia than after antegrade or 
retrograde cardioplegia; however, the differenees 
were not statistically significant. Acid production 
tended to be greater after retrograde cardioplegia 
immediately after crossclamp removal and was sig- 
nificantly greater (fi < 0.05) than that in antegrade 
cardioplegia 10 minutes after CPB. 
Metabolic response to atrial pacing. The meta- 
bolic response to atrial pacing during and after CPB 
are summarized in Table III. Atrial pacing during 
CPB increased oxygen extraction (p < 0.05) com- 
pared with the baseline value after combination and 
retrograde cardioplegia but not after antegrade car- 
dioplegia. Atrial pacing during CPB resulted in 
lactate production after antegrade and retrograde 
cardioplegia but in lactate xtraction after combina- 
tion cardioplegia. Atrial paeing during CPB tended 
to increase acid production compared with baseline 
values after antegrade (p = 0.06) and retrograde 
cardioplegia (p = 0.07) but not after combination 
cardioplegia (p = 0.35); however, the differences 
were not statistically significant. Ten minutes after 
discontinuation of CPB atrial pacing resulted in 
similarly small changes in oxygen extraction and 
lactate extra ction after antegrade and combination 
cardioplegia but in lactate production after retro- 
grade cardioplegia. 
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Fig. 2. Myocardial oxygen consumption (MVO2), lactate 
release (LR), and acid release (AR) at 30 minutes (XCL 
30') and 50 minutes (XCL 50') of cardioplegic arrest are 
illustrated in three cardioplegic groups. Combination car- 
dioplegic group is divided into antegrade and retrograde 
cardioplegic solution delivery. Myocardial oxygen con- 
sumption was greater with antegrade and intermittent 
antegrade delivery of cardioplegic solution in combination 
cardioplegia. Lactate release and acid release increased 
with time in retrograde cardioplegia but not in antegrade 
or combination cardioplegia. Intermittent antegrade de- 
livery of cardioplegic solution in combination cardioplegia 
resulted in greatest lactate release and acid release during 
crossclamp period, it, Antegrade cardioplegia; CA, inter- 
mittent antegrade delivery of cardioplegic solution in 
combination group; CR, retrograde delivery of cardiople- 
gic solution in combination group; R, retrograde cardio- 
plegia. 
Myocardial tissue lactate. Left ventricular tissue 
lactate concentrations increased immediately after 
antegrade cardioplegia but not after combination or 
retrograde cardioplegia (p = 0.004 by analysis of 
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Fig. 3. Myocardial oxygen extraction (Oßx), lactate pro- 
duction (LP), and acid production (AP) before crossclamp 
(pre XCL), immediately after crossclamp removal (XCL 
oft), 10 minutes after crossclamp removal (offlO'), and 10 
minutes after cessation of CPB (CPB 10'). Myocardial 
oxygen extraction was greater after retrograde cardiople- 
gia (R). Lactate production was found in all three groups 
immediately after crossclamp release and tended to be 
less after combination cardioplegia (C) than after ante- 
grade (A) or retrograde cardioplegia; however, differences 
were not statistically significant. Acid production tended 
to be greater after retrograde cardioplegia immediately 
after crossclamp removal and was significantly greater 
(p < 0.05) than that after antegrade cardioplegia 10 
minutes after CPB. NS, Not significant. 
variance, Fig. 4). Right ventricular lactate levels also 
increased immediately after crossclamp release (p = 
0.02) but there were no differences among car- 
dioplegic groups. 
Adenine nucleotides and degradation products. 
There were no differences between groups in the 
baseline levels of left ventricular ATP, ADP, AMP, 
or TDP (Table IV). Percentage change from base- 
line values is shown in Fig. 5. The decreases in ATP 
levels were greatest after retrograde cardioplegia 
Table III. Metabolic response to atrial pacing 
(percent change) 
Antegrade Combination Retrograde 
During CPB 
OzEx 63 -+ 47 63 + 25* 20 _+ 7* 
LP 36 ± 58 -22  ± 197 49 ± 285 
AP 24 -+ 12 14 -+ 14 26 ± 13 
After CPB 
O2Ex 7 ± 6 1 -+ 9 -1  -+ 4 
LP -42  -+ 50 42 + 98 -117 ± 117" 
AP 14 ± 12 12 ± 8 12 ± 10 
The results are presented as percentage change from baseline. Oßx, 
Oxygen extraction; LP, lactate production;AP, acid production; after CPB, 
10 minutes after discontinuation f CPB. 
*p < 0.05 atrial pacing different from baseline. 
and least after combination cardioplegia t the time 
of crossclamp release (p < 0.05). There was no 
statistical difference in the decrease of ADP or AMP 
levels. TDP rose to a significantly higher level after 
retrograde cardioplegia than after antegrade or 
combination cardioplegia t the time of crossclamp 
removal (p < 0.05). Ten minutes after crossclamp 
release, ATP values were lowest after retrograde 
cardioplegia but the difference was not statistically 
significant (p = 0.10). 
There were no significant differences between 
groups in baseline right ventricular values of ATP, 
ADP, AMP, and TDP (Table IV). At the time of 
crossclamp removal, there were no significant dif- 
ferences in ATP, ADP, and AMP levels among the 
three groups. However, TDP levels were signifi- 
cantly greater in the retrograde group than in the 
combination group. There were no differences in 
ATP, ADP, AMP, or TDP levels among groups 
after reperfusion (Table IV). 
Hemodynamie measurements. Hemodynamic 
measurements are summarized in Tables V and 
VI. Before initiation of CPB afterload (mean 
arterial pressure) was lower and cardiac index was 
higher in the combination group but there were 
no differences in left ventricular stroke work 
index. There were no other differences among 
groups before CPB. Heart rate increased after 
operation in all groups: 66 + 2 beats/min before 
initiation of CPB, 86 + 1 beats/min 10 minutes 
after CPB, 86 -+ 2 beats/min i hour after CPB, 87 
_+ 1 beats/min 4 hours after CPB, 87 _+ 2 beats/ 
min 12 hours after CPB, and 87 _+ 2 beats/min 24 
hours after CPB. Left ventricular stroke work 
index and cardiac index were greater (p < 0.05) 
after combination cardioplegia than after retro- 
grade cardioplegia t 10 minutes after CPB de- 
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Fig. 4. Myocardial lactate concentrations i  left and right ventricles before crossclamping (pre), at time of 
crossc lamp remova l  (XCL oft), and 10 minutes  after  c rossc lamp remova l  (I0') are i l lustrated. Left  
ventr icu lar  lactate concent ra t ions  increased immedia te ly  af ter  antegrade  (A) but  not  after  combinat ion  (C) 
or re t rograde  (R) card iop leg ia  (p = 0.004) by analysis of  var iance.  R ight  ventr icu lar  lactate levels also 
increased immedia te ly  after  c rossc lamp re lease (p = 0.02) but  there  were no  di f ferences between 
cardioplegic  groups.  NS, Not  signif icant. 
Table IV. Myocardial adenine nucleotides and adenine nucleotide degradation products 
Left ventricle Right ventricle 
Antegrade Combination Retrograde Antegrade Combination Retrograde 
ATP (>mol/gm dry weight) 
pre XCL 16.9 -+ 1.3 16.9 -+ 1.5 19.2 _+ 2.9 15.5 +_ 1.9 11.9 _+ 3.4 14.2 _+ 3.9 
XCL oft 12.7 _+ 0.9 14.9 _+ 1.0" 10.7 -+ 1.0 9.1 +- 1.9 11.8 _+ 1.1 11.3 -+ 1.6 
XCL oft 10' 13.7 + 1.3 13.3 + 1.8 12.8 +- 1.6 12.3 _+ 1.4 11.9 + 1.2 11.2 + 1.6 
ADP (/~mol/gm dry weight) 
pre XCL 2.06 +_ 0.25 2.01 _+ 0.10 1.96 +_ 0.45 1.34 +_ 0.11 2.37 _+ 1.09 1.34 _+ 0.40 
XCL oft 2.42 +_ 0.35 2.22 +_ 0.20 1.86 -4- 0.29 1.11 _+ 0.18 1.64 _+ 0.21 1.57 _+ 0.19 
XCL oft 10' 1.92 _+ 0.17 2.27 _+ 0.22 2.37 _+ 0.19 2.05 -4- 0.27 1.96 _+ 0.25 2.14 _+ 0.51 
AMP (/,mol/gm dry weight) 
pre XCL 0.15 + 0.04 0.14 + 0.01 0.09 -+ 0.03 0.09 + 0.03 0.31 _+ 0.25 0.07 _+ 0.04 
XCL oft 0.32 _+ 0.08 0.20 _+ 0.02 0.19 -4- 0.01 0.13 -4- 0.01 0.16 -+ 0.03 0.14 + 0.02 
XCL oft 10' 0.22 + 0.03 0.24 -+ 0.04 0.31 -+ 0.10 0.45 _+ 0.20 0.35 _+ 0.15 0.41 _+ 0.16 
TDP (/xmol/gm dry weight) 
pre XCL 0.33 + 0.07 0.40 + 0.05 0.19 _+ 0.14 0.36 _+ 0.12 0.34 _+ 0.12 0.23 _+ 0.02 
XCL oft 0.83 +- 0.15" 0.65 + 0.18" 1.85 _+ 0.16 1.04 _+ 0.29 0.67 +- 0.12" 2.17 + 0.70 
XCL oft 10' 0.50 -4- 0.14 0.61 _+ 0.17 0.45 _+ 0.04 0.54 -+ 0.10 0.54 -+ 0.05 0.39 + 0.09 
Values are given as mean plus or minus the standard error of the mean. pre XCL, Before crossclamp; XCL oft, at the 
10', 10 minutes after crossclamp removal. 
*p < 0.05 versus retrograde group. 
time of crossclamp removal; XCL oft 
spite similar filling pressures and afterload (mean 
arterial pressure) (p < 0.05 by analysis of covari- 
ance; Fig. 6 and Table V). The pulmonary capil- 
lary wedge pressure was greater (p < 0.05) after 
retrograde cardioplegia 24 hours after cessation 
of CPB (Table V). Right ventricular stroke work 
index was greater after combination cardioplegia 
than after retrograde cardioplegia 1 hour after 
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Fig. 5. Bar graph showing left ventricular ATP, ADP, 
AMP, and TDP concentrations at time of crossclamp 
removal (XCL oft) and 10 minutes after crossclamp re- 
moval (XCL 10') as percentages of baseline value. De- 
creases in ATP levels were greatest after retrograde 
cardioplegia (R) and least after combination cardioplegia 
(C) at time of crossclamp release (p < 0.05). There was no 
statistical difference in decrease of ADP or AMP levels. 
TDP rose to significantly higher level after retrograde 
cardioplegia than after antegrade (M) or combination 
eardioplegia at time of crossclamp removal (p < 0.05). NS, 
Not significant. 
CPB despite a higher afterload (mean pulmonary 
artery pressure) and a similar filling pressure 
(right atrial pressure) (Fig. 7 and Table VI). 
Excluding the six patients who had either inotro- 
pic support or intraaortic balloon pumping after 
operation did not change the conclusions or the 
statistical differences found when these patients 
were included. Among the 25 patients who received 
warm antegrade cardioplegia, one patient who re- 
quired balloon pump support after operation had a 
higher left ventricular stroke work index and a lower 
pulmonary wedge pressure than the mean. Exclud- 
ing the values of slightly increased stroke work index 
and lower pulmonary wedge pressure from this 
patient did not change the statistical evaluation. 
Among the 25 patients who received warm combi- 
nation cardioplegia, three patients required either 
inotropic support (2 patients) or balloon pump 
support (1 patient). One patient (with a balloon 
pump) had a lower left ventricular stroke work index 
and a higher wedge pressure than the mean. Exclud- 
ing these three patients did not change the mean 
cardiac index or stroke work index, which was 
greater after combination cardioplegia than after 
retrograde cardioplegia. Among the 25 patients who 
received warm retrograde cardioplegia, two patients 
required balloon pump support after operation. The 
left ventricular stroke work indices in these patients 
10 minutes after discontinuation of CPB were 12 
and 16 gm" m/m 2 with pulmonary wedge pressures 
of 18 and 20 mm Hg, respectively. The exclusion of 
values from these two patients did not change the 
mean values, which were statistically significantly 
different (p < 0.05) from those of combination 
cardioplegia. 
Postoperative release of CK-MB. There was no 
significant difference in total CK-MB release among 
groups (antegrade 1407 _+ 175, combination 2018 +_ 
394, retrograde 2002 2 242 U × hr/L). When the four 
patients with electrocardiographic changes were ex- 
cluded, the CK-MB values were also not different 
among groups (antegrade 1407 2 175, combination 
1982 _+ 362, retrograde 1982 2 231 U × hr/L). 
Discussion 
Normothermic cardioplegia may allow resuscita- 
tion of the ischemic myocardium and immediate 
functional recovery in patients with high-risk condi- 
tions, reducing the morbidity and mortality. 1°' 11 
However, inadequate distribution of the solution or 
interruption of normothermic cardioplegic solution 
delivery may induce anaerobic metabolism and 
warm ischemic injury. Therefore delivery of the 
solution for normothermic ardioplegia must be 
continuous and homogeneous. To avoid ischemic 
myocardial damage during warm heart operations, 
improved techniques of cardioplegic solution deliv- 
ery are required. 4'6, 11 
This study was designed to evaluate the myocar- 
dial metabolic and ventricular functional response 
to different cardioplegic techniques. In these pa- 
tients with low-risk conditions no differences in 
clinical outcomes were anticipated and none were 
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Table V. Lift ventricular hemodynamic measurements 
Before CPB 10 min 1 hr 4 hr 12 hr 24 hr 
LVSWI (gin. m/m 2) 
A 33.2 + 1.5 25.3 + 1.7" 28.4 + 1.8 32.0 -- 1.5 29.8 _+ 1.4 30.4 +_ 1.1 
C 33.6 _+ 2.3 26.5 -+ 1.8"~ 26.6 _+ 1.7 28.7 _+ 1.8 27.8 -4- 1.5" 25.9 + 1.6" 
R 37.3 _+ 2.4 20.8 -+ 1.4" 24.6 _+ 1.2" 28.6 _+ 1.9" 27.4 -+ 2.0* 28.5 + 1.7" 
PCWP (mm Hg) 
A 12.8 -4- 1.0 13.0 -- 0.7 11.1 -+ 0.6 11.6 -+ 0.8 12.5 -- 0.7 11.5 _+ 0.5 
C 10.6 -+ 0.7 14.5 _+ 0.8* 10.8 -+ 1.1 11.1 +- 0.6 12.0 +- 1.0 12.6 _+ 0.9 
R 11.4 -+ 0.6 14.7 -+ 0.8* 10.0 + 0.7 11.5 -+ 0.9 13.8 _+ 1.0 13.9 +- 0.9"~: 
MAP (mm Hg) 
A 79.7 -+ 1.8 65.5 -+ 1.5" 69.9 -+ 2.7* 77.0 + 2.3 74.0 _+ 2.1 73.8 -+ 1.8 
C 71.9 +- 2.9§ 65.3 -+ 2.0 68.6 -+ 2.6 73.5 + 2.4 72.7 _+ 2.3 70.5 +- 2.6 
R 80.8 -+ 2.3 64.0 _+ 1.6" 69.4 - 1.2" 74.7 + 2.9* 70.2 +- 2.0* 75.7 -+ 1.7" 
CI (L/min/m 2) 
A 2.3 _+ 0.1 2.9 -+ 0.1" 2.9 + 0.2* 3.0 _+ 0.1" 3.0 -+ 0.1" 3.0 -+ 0.1" 
C 2.7 _+ 0.1:~ 3.2 _+ 0.1*t 2.9 _+ 0.1t 3.0 + 0.1 3.0 _+ 0.1 2.8 -+ 0.1 
R 2.4 +_ 0.1 2.7 _+ 0.1 2.6 -+ 0.1 2.9 - 0.2* 2.9 _+ 0.1' 2.9 + 0.1" 
Values are given as mean plus or minus the standard error of the mean.pre, Before CPB; 10 min, 10 minutes after CPB; 1 hr, 1 hour after CPB; 4 hr, 4 hours 
after CPB; 12 hr, 12 hours after CPB; 24 hr, 24 hours after CPB; LVSWI, left ventricular stroke work index; A, antegrade cardioplegia; C, combination 
cardioplegia; R, retrograde cardioplegia; PCWP, pulmonary capillary wedge pressure; MAP, mean arteriaI pressure; CI, cardiac index. 
*p < 0.05 versus before CPB. 
tp < 0.05 versus retrograde cardioplegia. 
Sp < 0.05 versus antegrade cardioplegia. 
§p < 0.05 versus antegrade and retrograde cardioptegia. 
Table VI. Right ventricular hemodynamic measurements 
Before CPB 10 min 1 hr 4 hr 12 hr 24 hr 
RVSWI (gm. m/m 2) 
A 3.7 +- 0.3 4.1 _+ 0.6 2.9 -+ 0.4 3.8 _+ 0.4 3.9 +- 0.3 3.6 -+ 0.3 
C 4.3 _+ 0.4 4.7 + 0.5 3.6 _+ 0.4* 2.9 -+ 0.3t 3.5 -+ 0.3 3.5 _+ 0.3 
R 3.6 _+ 0.5 3.6 -+ 0.4 1.9 +_ 0.2t 3.2 _+ 0.4 3.7 _+ 0.4 3.6 _+ 0.2 
RAP (mm Hg) 
A 9.2 _+ 0.6 10.0 +- 0.8 9.3 _+ 0.7 10.2 -+ 0.7 9.5 -+ 0.7 10.0 _+ 0.8 
C 8.0 _+ 0.5 10.9 -+ 0.6t 9.8 _+ 0.6 9.3 + 0.6 9.4 _+ 0.6 9.6 +_ 0.7 
R 8.8 -+ 0.7 11.0 ± 0.8 9.8 -+ 0.9 9.0 -+ 0.6 10.3 -+ 0.9 10.8 -+ 0.9 
MAP (mm Hg) 
A 16.7 -+ 0.9 18.3 _+ 0.8 15.2 _+ 0.6 17.9 -+ 0.9 17.4 _+ 0.9 17.3 _+ 0.8 
C 15.8 _+ 1.0 20.0 _+ 1.0t 17.6 -+ 1.1' 15.7 _+ 0.7 17.5 _+ 1.1 17.7 _+ 1.0 
R 15.6 -+ 0.7 19.1 _+ 0.9t 14.4 -+ 0.8 16.3 _+ 1.1 18.0 _+ 1.0 18.3 _+ 1.1 
Vaines are given as mean plus or minus the standard error of the mean. RVSWI,, Right ventricular stroke work index; RAP, right atrial pressure; MPA, mean 
pulmonary artery pressure. Other abbreviations as in Table V. 
*p < 0.05 versus retrograde. 
?p < 0.05 versus before CPB. 
found. Because we found differences in the meta- 
bolic and hemodynamic response to elective cardiac 
operations, we plan to perform a prospective, ran- 
domized trial in patients with high-risk conditions. 
The patients were first evaluated by an intention-to- 
treat process. Differences were discovered in both 
myocardial metabolism and ventricular function. 
However, patients who require inotropic or balloon 
pump support have postoperative hemodynamics 
that are not dependent on the cardioplegic tech- 
niques. Therefore analysis was also done with the 
exclusion of the six patients in whom these therapies 
were used, and significant differences were main- 
tained among groups. The inclusion of patients who 
received inotropic support does not permit an as- 
sessment of ventricular function independent of 
preload or afterload. No significant differences were 
found among groups in the amount of CK-MB 
released after operation. The analysis was done first 
by an intention-to-treat process and then for efficacy 
by excluding the four patients who had electrocar- 
diographic changes. Neither analysis found signifi- 
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Fig. 6. Relationships between left ventricular stroke 
work index (LVSWI) and pulmonary capillary wedge 
pressure (PCWP) before CPB (pre) and 10 minutes (10 
min) and 1 hour (1 hr) after CPB are depicted. Left 
ventricular stroke work index was greatest after combina- 
tion cardioplegia (circles) and least after retrograde car- 
dioplegia (triangles; R) despite similar filling pressure 
(pulmonary capillary wedge pressure) 10 minutes after 
cessation of CPB (t7 < 0.05 by analysis of covariance). 
Squares represent values for antegrade cardioplegia; NS, 
not significant. 
cant differences among groups. The primary analysis 
in this study was the intention-to-treat analysis and 
the secondary analysis was the efficacy evaluation of 
various cardioplegic techniques. The perioperative 
measurements of the three patients who died after 
operation were included in this evaluation because 
the deaths occurred more than 72 hours after the 
operation. 
Antegrade cardioplegia. In previous studies we 
found that warm antegrade delivery of cardioplegic 
solution improved myocardial metabolic recovery, 
increased early postoperative end systolic elastance 
and preload recruitable stroke work, and improved 
early diastolic relaxation compared with results with 
cold antegrade delivery of cardioplegic solution. 1' 12 
However, animal studies demonstrated that nutri- 
tive flow to the myocardium supplied by an occluded 
left anterior descending coronary artery was sub- 
stantially reduced with antegrade delivery of car- 
dioplegic solution, particularly in the subendo- 
cardium, z In the setting of acute left anterior 
descending coronary occlusion postischemic global 
and regional systolic function was depressed after 
warm antegrade cardioplegic solution delivery com- 
pared with that after warm retrograde cardioplegic 
solution delivery. 11 Furthermore, the anterior myo- 
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Fig. 7. Relationships between right ventricular stroke 
work index (RVSWI) and right atrial pressure (RAP) 
before CPB (pre) and 10 minutes (10 min) and 1 hour 
(1 hr) after CPB are depicted. Right ventricular stroke 
work index was greatest after combination cardioplegia 
(C) and least after retrograde cardioplegia (R) despite 
similar filling pressure (right atrial pressure) at 1 hour 
after CPB. NS, Not significant;.4, antegrade cardioplegia. 
cardium may not be perfused during antegrade 
cardioplegic solution delivery when left anterior 
descending coronary artery revascularization with 
an internal mammary artery graft precludes vein 
graft infusions. In the present study myocardial 
lactate concentrations increased significantly in the 
territory of the left anterior descending coronary 
artery after antegrade cardioplegia but not after 
combination or retrograde cardioplegia. This lactate 
increase is the first evidence in human beings that 
warm antegrade delivery of cardioplegic solution 
does not adequately perfuse the territory of the left 
anterior descending artery when a mammary artery 
graft is used. 
Retrograde cardioplegia. Retrograde delivery of 
coronary sinus cardioplegic solution has been pro- 
posed to be a superior technique of myocardial 
protection because it permits delivery of cardiople- 
gic solution beyond coronary obstructions or critical 
coronary stenoses. 2' 13-15 However, shunting of car- 
dioplegic solution administered in a retrograde fash- 
ion away from nutrient capillaries into venous inu- 
soids and thebesian channels may limit cardioplegic 
solution distribution. 3' 16 In a recent study we found 
that warm retrograde delivery of cardioplegic solu- 
tion results in decreasing anaerobic lactate produc- 
tion when flow rates are increased from 50 to 200 
tal/min. 6However, further increases to 300 or 500 
ml/min increased the shunt flow without increasing 
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myocardial oxygen extraction and without reducing 
anaerobic lactate production. Further, cardioplegic 
solution administered in a retrograde fashion may 
inadequately perfuse the right ventricle and poste- 
rior left ventricle or posterior septum. 2'3, 15, 16 We 
also demonstrated that warm retrograde delivery of 
cardioplegic solution resulted in greater anaerobic 
lactate production during and after cardioplegic 
arrest compared with results with other cardioplegic 
techniques.5, t7, is In this study lactate and acid 
release increased with time during retrograde car- 
dioplegia but not during antegrade or combination 
cardioplegia. In addition, myocardial lactate levels 
were higher than baseline values in the right but not 
the left ventricle, which suggests incomplete right 
ventricular protection. Significant decreases in ATP 
levels in the left ventrMe and significant accumula- 
tions in TDP levels in both left and right ventricles 
after retrograde cardioplegia suggest hat inade- 
quate cardioplegic solution delivery resulted in ATP 
metabolism to diffusible precursors that were not 
washed out by retrograde delivery of cardioplegic 
solution. 7 The depletion of ATP, accumulation of 
TDP, and increased lactate and acid release are 
consistent with more severe myocardial ischemia 
during retrograde cardioplegic solution delivery. 
The depressed metabolism ay have contributed to 
the depressed left and right ventricular function in 
the early postoperative period. Warm retrograde 
delivery of cardioplegic solution did not provide 
optimal myocardial protection for either the right 
ventricle or left ventricle. 
Combination cardioplegia. In a previous animal 
study that used radiolabeled microspheres, the dis- 
tribution of cardioplegic solution administered in an 
antegrade fashion was significantly different from 
that of cardioplegic solution administered in a ret- 
rograde fashion. 19 To overcome this disparity, inter- 
mittent antegrade and then retrograde cold car- 
dioplegic solutions were given intermittently in 
animals 2° and patients. 2t' 22 Intermittent infusions of 
antegrade and then retrograde cold blood cardiople- 
gic solutions every 20 minutes provided homoge- 
neous myocardial cooling, complete left and right 
ventricular functional recovery in animals, and ex- 
cellent clinical outcomes in patients. However, this 
cardioplegic technique cannot be applied to warm 
heart operations. Therefore we developed the tech- 
nique of continuous retrograde delivery of cardiople- 
gic solution with intermittent antegrade infusions. 
During combination cardioplegia, intermittent 
antegrade infusions resulted in an increase in myo- 
cardial oxygen consumption and lactate and acid 
release, which suggests a washout of anaerobic 
metabolites and repayment of the oxygen debt ac- 
cumulated uring retrograde cardioplegic solution 
infusion. Combination cardioplegia prevented the 
progressive increase in lactate and acid release 
during the crossclamp eriod that is seen with 
retrograde cardioplegia. After crossclamp release 
lactate and acid production were least after combi- 
nation cardioplegia, nd postoperative atrial pacing 
did not induce lactate production, which suggests 
better myocardial protection with this technique. 
Combination cardioplegia best preserved ATP lev- 
els and prevented the accumulation of myocardial 
lactate in the left but not the right ventricle. Both 
left and right ventricular function were better after 
combination cardioplegia. 
In summary, intermittent antegrade infusions of 
cardioplegic solution during continuous warm retro- 
grade cardioplegic solution delivery provided homo- 
geneous distribution and prevented ischemic myo- 
cardial injury during warm heart operations. 
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